HomeCLDI • NYSEAMERICAN
Calidi Biotherapeutics Inc
add
$0.36
2.22%
After Hours:(3.59%)+0.013
$0.37
Closed: Jun 5, 7:59:47 PM UTC-4 · USD · NYSEAMERICAN · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.06M | -25.03% |
Net income | -4.99M | 30.99% |
Net profit margin | — | — |
Earnings per share | -0.19 | 90.53% |
EBITDA | -4.97M | 25.25% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.56M | 823.97% |
Total assets | 15.06M | 103.43% |
Total liabilities | 7.77M | -64.67% |
Total equity | 7.30M | — |
Shares outstanding | 33.59M | — |
Price to book | 1.74 | — |
Return on assets | -86.54% | — |
Return on capital | -120.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.99M | 30.99% |
Cash from operations | -7.13M | -86.14% |
Cash from investing | -7.00K | -40.00% |
Cash from financing | 8.11M | 169.10% |
Net change in cash | 970.00K | 220.35% |
Free cash flow | -4.58M | -1,507.63% |
Previous close
$0.36
Day range
$0.34 - $0.37
Year range
$0.34 - $3.89
Market cap
11.21M USD
Avg Volume
360.09K
P/E ratio
-
Dividend yield
-
About
Founded
2014
Website
Employees
28
